OXON’s RWE solutions at the 39th International Conference on PharmacoEpidemiology, ICPE 2023. The Global Home for the Science of Real-World August 23-27, 2023. | Halifax Convention Centre | Halifax, Nova Scotia, Canada OXON will be supporting ICPE 2023 as an exhibitor, presenting its expertise in RWE during this virtual and in-person interactional scientific event as well…
Read more
OXON’s real-world studies at the 38th International Conference on PharmacoEpidemiology, ICPE 2022. Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community August 24-28, 2022 | Bella Center Copenhagen | Copenhagen, Denmark At OXON we are excited to be supporting ICPE 2022 as an exhibitor, presenting our capabilities and research during this in-person event for scientific and…
Read more
OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
OXON will be supporting the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia on August 24-28, 2019.
22nd – 23rd May 2019,
Holiday Inn London Kensington Hotel, London UK
Nawab Qizilbash, Head of OXON, will be speaking about PASS Studies.
Nawab Qizilbash will speak and show a selection of practical examples and case studies under the title “Trials with observational designs”
OXON will present a review and discuss lessons learned from risk minimisation evaluation studies at the EFPIA PV Expert Group
OXON will be presenting at the 20th Annual European Congress of ISPOR:
two poster presentations focused on Clinical Outcomes Studies
